All stock lists
Amn Healthcare Services Inc (New York Stock Exchange:AMN)
US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
48.26+0.24 (+0.51%)
Insider Score
––Not scored
AMN Insider Score
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
AMN analyst forecast
AMN analyst consensus
Moderate Buy3 ratings
Buy 2 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AMN 12-month price target
$43.00-10.6% downsideaverage of 1 firm
$43.00High
$43.00Low
Best analysts covering AMN
- Truist Securities20%success rate · 10 calls
- BMO Capital18%success rate · 11 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AMN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| BMO Capital | Outperform | $43.00 | +18.4% | Reiterated | 2026-10-09 | |
| BMO Capital | Outperform | $40.00 | +18.5% | Reiterated | 2026-09-11 | |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-08-14 |
| — | UBS | Neutral | — | — | Reiterated | 2026-08-07 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-22 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-06-23 |
| — | UBS | Neutral | — | — | Reiterated | 2026-05-13 |
| — | Baird | Neutral | — | — | Reiterated | 2026-05-11 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2026-05-11 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-05-08 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-02-23 |
| — | Baird | Neutral | — | — | Reiterated | 2026-02-20 |
| — | UBS | Neutral | — | — | Reiterated | 2026-02-20 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2026-01-15 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2025-12-19 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2025-11-07 |
| — | UBS | Neutral | — | — | Reiterated | 2025-11-07 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-10-13 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2025-09-10 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-08-12 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2025-08-11 |
| — | UBS | Neutral | — | — | Reiterated | 2025-05-13 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-04-15 |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-02-24 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2025-02-24 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-02-21 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-02-06 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-01-24 |
| — | Jefferies | Hold | — | — | Reiterated | 2024-11-13 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2024-11-11 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-11-08 |
| — | William Blair | Market Perform | — | — | Downgraded | 2024-11-08 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-10-22 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-10-21 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2024-10-07 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-10-04 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-08-13 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2024-08-12 |
| — | UBS | Neutral | — | — | Reiterated | 2024-08-09 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2024-05-15 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2024-05-13 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-05-10 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-04-22 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-02-26 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2024-02-20 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-02-16 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-12-05 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-11-06 |
| — | Jefferies | Hold | — | — | Downgraded | 2023-11-03 |
| — | Benchmark | Hold | — | — | Downgraded | 2023-11-03 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2023-08-07 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-08-04 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-08-04 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2023-08-04 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2023-05-08 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-05-05 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-05-05 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-05-02 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-04-03 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2023-02-21 |
AMN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-19 | 0.22 | 0.22 | $723.7M | $748.2M |
| 2026-05-07 | 1.60 | 2.10 | $1.23B | $1.38B |
| 2026-08-06 | 0.19 | 0.77 | $628.4M | $673.2M |
| 2026-11-05 | 0.23 | 0.00 | $649.5M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.